BEAM Message Board Post 9244722 | Beam Therapeutics Inc.
home / stock / beam / beam message board
hollister
(investorshub)
Posted on: Jul/15/2022 22:35:12
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169414454
https://www.the-scientist.com/news-opinion/first-person-dosed-in-novel-gene-editing-clinical-trial-7
News, Short Squeeze, Breakout and More Instantly...
-
CAMBRIDGE, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that its chief financial officer, Terry-Ann Burrell, will be leaving the company effective August 9, 2024...